These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1551 related items for PubMed ID: 23477634

  • 1. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C.
    Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
    [Abstract] [Full Text] [Related]

  • 2. Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.
    Roberts I, Shakur-Still H, Aeron-Thomas A, Beaumont D, Belli A, Brenner A, Cargill M, Chaudhri R, Douglas N, Frimley L, Gilliam C, Geer A, Jamal Z, Jooma R, Mansukhani R, Miners A, Pott J, Prowse D, Shokunbi T, Williams J.
    Health Technol Assess; 2021 Apr; 25(26):1-76. PubMed ID: 33928903
    [Abstract] [Full Text] [Related]

  • 3. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    CRASH-2 trial collaboratorsClinical Trials Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S.
    Lancet; 2010 Jul 03; 376(9734):23-32. PubMed ID: 20554319
    [Abstract] [Full Text] [Related]

  • 4. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.
    Perel P, Al-Shahi Salman R, Kawahara T, Morris Z, Prieto-Merino D, Roberts I, Sandercock P, Shakur H, Wardlaw J.
    Health Technol Assess; 2012 Jul 03; 16(13):iii-xii, 1-54. PubMed ID: 22417901
    [Abstract] [Full Text] [Related]

  • 5. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
    CRASH-2 collaboratorsClinical Trials Unit, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. crash@lshtm.ac.uk, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T.
    Lancet; 2011 Mar 26; 377(9771):1096-101, 1101.e1-2. PubMed ID: 21439633
    [Abstract] [Full Text] [Related]

  • 6. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT.
    Roberts I, Shakur-Still H, Afolabi A, Akere A, Arribas M, Austin E, Bal K, Bazeer N, Beaumont D, Brenner A, Carrington L, Chaudhri R, Coats T, Gilmore I, Halligan K, Hussain I, Jairath V, Javaid K, Kayani A, Lisman T, Mansukhani R, Miners A, Mutti M, Nadeem MA, Pollok R, Prowse D, Simmons J, Stanworth S, Veitch A, Williams J.
    Health Technol Assess; 2021 Oct 26; 25(58):1-86. PubMed ID: 34663491
    [Abstract] [Full Text] [Related]

  • 7. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial.
    Williams-Johnson JA, McDonald AH, Strachan GG, Williams EW.
    West Indian Med J; 2010 Dec 26; 59(6):612-24. PubMed ID: 21702233
    [Abstract] [Full Text] [Related]

  • 8. Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial.
    Perel P, Prieto-Merino D, Shakur H, Roberts I.
    Health Technol Assess; 2013 Jun 26; 17(24):1-45, v-vi. PubMed ID: 23782457
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial.
    Guerriero C, Cairns J, Perel P, Shakur H, Roberts I, CRASH 2 trial collaborators.
    PLoS One; 2011 May 03; 6(5):e18987. PubMed ID: 21559279
    [Abstract] [Full Text] [Related]

  • 10. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, Ciccone A, Collins R, Dineen RA, Duley L, Egea-Guerrero JJ, England TJ, Karlinski M, Krishnan K, Laska AC, Law ZK, Ovesen C, Ozturk S, Pocock SJ, Roberts I, Robinson TG, Roffe C, Peters N, Scutt P, Thanabalan J, Werring D, Whynes D, Woodhouse L, Bath PM.
    Health Technol Assess; 2019 Jul 03; 23(35):1-48. PubMed ID: 31322116
    [Abstract] [Full Text] [Related]

  • 11. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
    CRASH-3 trial collaborators.
    Lancet; 2019 Nov 09; 394(10210):1713-1723. PubMed ID: 31623894
    [Abstract] [Full Text] [Related]

  • 12. Antifibrinolytic drugs for treating primary postpartum haemorrhage.
    Shakur H, Beaumont D, Pavord S, Gayet-Ageron A, Ker K, Mousa HA.
    Cochrane Database Syst Rev; 2018 Feb 20; 2(2):CD012964. PubMed ID: 29462500
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
    HALT-IT Trial Collaborators.
    Lancet; 2020 Jun 20; 395(10241):1927-1936. PubMed ID: 32563378
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antifibrinolytic drugs for acute traumatic injury.
    Roberts I, Shakur H, Ker K, Coats T, CRASH-2 Trial collaborators.
    Cochrane Database Syst Rev; 2012 Jun 20; 12():CD004896. PubMed ID: 23418644
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 78.